Literature DB >> 14712152

Prostatitis as a risk factor for prostate cancer.

Rosebud O Roberts1, Erik J Bergstralh, Sarah E Bass, Michael M Lieber, Steven J Jacobsen.   

Abstract

BACKGROUND: The association of infection or inflammation of the prostate with prostate cancer has been suggested but not established. This study was undertaken to investigate this association.
METHODS: Cases were Olmsted County, Minnesota, residents with histologically proven prostate cancer diagnosed between January 1980 and December 1996. Cases (n = 409) were each matched to 2 control subjects (n = 803) on age at diagnosis of prostate cancer, residency in Olmsted County, and duration of the community medical record. The medical record of each subject was reviewed for a history of acute or chronic bacterial prostatitis or chronic pelvic pain syndrome (inflammatory type).
RESULTS: The relative odds of prostate cancer were elevated in men with history of any type of prostatitis (odds ratio [OR] = 1.7; 95% confidence interval [CI] = 1.1-2.6) or acute prostatitis (2.5; 1.3-4.7). The mean time from most recent episode of acute prostatitis to the diagnosis of prostate cancer was 12.2 years. After exclusion of men with acute prostatitis 2 years before the index date, the relationship was somewhat reduced (1.9; 0.9-3.8). Chronic bacterial prostatitis was more weakly associated with prostate cancer (1.6; 0.8-3.1), whereas chronic pelvic pain syndrome was not associated at all (0.9; 0.4-1.8).
CONCLUSIONS: Infection in the form of acute or chronic bacterial prostatitis may be associated with prostate cancer. However, our data do not provide compelling evidence to support this. As a result of the limitations of current methods of assessing chronic prostatitis, biochemical or tissue markers of infection or inflammation of the prostate may help clarify their role in the pathogenesis of prostate cancer.

Entities:  

Mesh:

Year:  2004        PMID: 14712152     DOI: 10.1097/01.ede.0000101022.38330.7c

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  38 in total

1.  Racial differences in the relationship between clinical prostatitis, presence of inflammation in benign prostate and subsequent risk of prostate cancer.

Authors:  B A Rybicki; O N Kryvenko; Y Wang; M Jankowski; S Trudeau; D A Chitale; N S Gupta; A Rundle; D Tang
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-12-01       Impact factor: 5.554

2.  Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy.

Authors:  Antonio B Porcaro; Giovanni Novella; Daniele Mattevi; Leonardo Bizzotto; Giovanni Cacciamani; Nicolò De Luyk; Irene Tamanini; Maria A Cerruto; Matteo Brunelli; Walter Artibani
Journal:  Curr Urol       Date:  2016-05-20

Review 3.  The inflammatory microenvironment and microbiome in prostate cancer development.

Authors:  Karen S Sfanos; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo
Journal:  Nat Rev Urol       Date:  2017-10-31       Impact factor: 14.432

4.  Prevalence of and risk factors for prostatitis in African American men: the Flint Men's Health Study.

Authors:  Lauren P Wallner; J Quentin Clemens; Aruna V Sarma
Journal:  Prostate       Date:  2009-01-01       Impact factor: 4.104

5.  CRISPR/Cas9-Mediated Point Mutation in Nkx3.1 Prolongs Protein Half-Life and Reverses Effects Nkx3.1 Allelic Loss.

Authors:  Cai Bowen; Maho Shibata; Hailan Zhang; Sarah K Bergren; Michael M Shen; Edward P Gelmann
Journal:  Cancer Res       Date:  2020-09-17       Impact factor: 12.701

Review 6.  Molecular markers in prostate cancer. Part I: predicting lethality.

Authors:  Sachin Agrawal; William D Dunsmuir
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

7.  Prostate cancer incidence in men with self-reported prostatitis after 15 years of follow-up.

Authors:  Markku H Vaarala; Aare Mehik; Pasi Ohtonen; Pekka A Hellström
Journal:  Oncol Lett       Date:  2016-06-13       Impact factor: 2.967

Review 8.  Inflammation and prostate cancer: a focus on infections.

Authors:  Siobhan Sutcliffe; Elizabeth A Platz
Journal:  Curr Urol Rep       Date:  2008-05       Impact factor: 3.092

9.  Antibiotic and anti-inflammatory use and the risk of prostate cancer.

Authors:  Nicholas A Daniels; Yea-Hung Chen; Stephen Bent
Journal:  BMC Res Notes       Date:  2009-04-17

10.  Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study.

Authors:  Iona Cheng; John S Witte; Steven J Jacobsen; Reina Haque; Virginia P Quinn; Charles P Quesenberry; Bette J Caan; Stephen K Van Den Eeden
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.